Global hemostasis diagnostics market to reach USD 3.2B by 2030

The global market for hemostasis diagnostics estimated at US$2.2 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the D Dimer segment is readjusted to a revised 5.7% CAGR for the next 8-year period.

The U.S. market is estimated at $594 Million, while China is forecast to grow at 8.5% CAGR
The hemostasis diagnostics market in the U.S. is estimated at US$594 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$736.3 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.9% and 4.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR. Research and Markets